Chronic administration of olanzapine affects Behavioral Satiety Sequence and feeding behavior in female mice

Eating and Weight Disorders

Volumn 13, Issue 3, 2008, Pages

  Coccurello, R ^a   D'Amato, F R ^a   Moles, Anna ^a  

^a CNR   (Italy)

Author keywords

Behavioral satiety sequence (BSS); Food intake; Mice; Olanzapine

Indexed keywords

OLANZAPINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; CHRONIC DRUG ADMINISTRATION; CONFERENCE PAPER; DRUG EFFECT; DYSLIPIDEMIA; EXTRAPYRAMIDAL SYMPTOM; FEEDING BEHAVIOR; FEMALE; FOOD INTAKE; HUNGER; METABOLIC INHIBITION; MOUSE; NONHUMAN; OBESITY; PALATABILITY; SATIETY; SCHIZOPHRENIA; SHIFT TO THE RIGHT; TREATMENT DURATION; WEIGHT GAIN;

ADMINISTRATION, ORAL; ANALYSIS OF VARIANCE; ANIMALS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; FEEDING BEHAVIOR; FEMALE; MICE; SATIETY RESPONSE; TIME FACTORS; WEIGHT GAIN;

EID: 56449113714     PISSN: 11244909     EISSN: 15901262     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. McIntyre R.S., McCann S.M., Kennedy S.H.: Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities. Can. J. Psychiatry, 46, 273-281, 2001.
2. Wetterling T.: Body weight gain with atypical antipsychotics. A comparative review. Drug. Saf. 24, 59-73, 2001.
3. Casey D.E., Zorn S.H.: The pharmacology of weight gain with antipsychotics. J. Clin. Psychiatry, 62, 4-10, 2001.
4. Baptista T., Zarate J., Joober R., Colasante C., Beaulieu S., Paez X., Hernandez L.: Drug induced weight gain, an impediment to successful pharmacotherapy: focus on antipsychotics. Curr. Drug. Targets, 5, 279-299, 2004.
5. Goudie A.J., Smith J.A., Halford J.C.: Characterization of olanzapine-induced weight gain in rats. J. Psychopharmacol. 16, 291-296, 2002.
6. Cope M.B., Nagy T.R., Fernández J.R., Geary N., Casey D.E., Allison D.B.: Antipsychotic drug-induced weight gain: development of an animal model. Int. J. Obes. (Lond.), 29, 607-614, 2005.
7. Coccurello R., Caprioli A., Ghirardi O., Conti R., Ciani B., Daniele S., Bartolomucci A., Moles A.: Chronic administration of olanzapine induces metabolic and food intake alterations: a mouse model of the atypical antipsychotic-associated adverse effects. Psychopharmacology (Berl.), 186, 561-571, 2006.
8. Berthoud H.R.: Multiple neural systems controlling food intake and body weight. Neurosci. Biobehav. Rev., 26, 393-428, 2002.
9. Antin J., Gibbs J., Holt J., Young R.C., Smith G.P.: Cholecystokinin elicits the complete behavioral sequence of satiety in rats. J. Comp. Physiol. Psychol., 89, 784-790, 1975.
10. Halford J.C, Wanninayake S.C., Blundell J.E.: Behavioral satiety sequence (BSS) for the diagnosis of drug action on food intake. Pharmacol. Biochem. Behav., 61, 159-168, 1998.
11. Blundell J.E., Lawton C.L., Cotton J.R., Macdiarmid J.I.: Control of human appetite: implications for the intake of dietary fat. Annu. Rev. Nutr., 16, 285-319, 1996.
12. Kirk S.L., Neill J.C., Jones D.N., Reynolds G.P.: Ziprasidone suppresses olanzapine-induced increases in ingestive behaviour in the rat. Eur. J. Pharmacol., 505, 253-254, 2004.
13. Wang G.J., Volkow N.D., Logan J., Pappas N.R., Wong C.T., Zhu W., Netusil N., Fowler J.S.: Brain dopamine and obesity. Lancet, 357, 354-357, 2001.
14. Richelson E., Souder T.: Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci., 68, 29-39, 2000.
15. Kalra S.P., Dube M.G., Pu S., Xu B., Horvath T.L., Kalra P.S.: Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr. Rev., 20, 68-100, 1999.
16. Masaki T., Yoshimatsu H., Chiba S., Watanabe T., Sakata T.: Targeted disruption of histamine H1-receptor attenuates regulatory effects of leptin on feeding, adiposity, and UCP family in mice. Diabetes, 50, 385-391, 2001.
17. McMinn J.E., Sindelar D.K., Havel P.J., Schwartz M.W.: Leptin deficiency induced by fasting impairs the satiety response to cholecystokinin. Endocrinology, 141, 4442-4448, 2000.
18. Morton G.J., Blevins J.E., Williams D.L., Niswender K.D., Gelling R.W., Rhodes C.J., Baskin D.G., Schwartz M.W.: Leptin action in the forebrain regulates the hindbrain response to satiety signals. J. Clin. Invest., 115, 703-710, 2005.
19. Schwartz M.W., Baskin D.G., Bukowski T.R., Kuijper J.L., Foster D., Lasser G., Prunkard D.E., Porte D. Jr, Woods S.C., Seeley R.J., Weigle D.S.: Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes, 45, 531-535, 1996.
20. Melkersson K.I., Hulting A.L., Brismar K.E.: Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses. J. Clin. Psychiatry, 61, 742-749, 2000.
21. Hosojima H., Togo T., Odawara T., Hasegawa K., Miura S., Kato Y., Kanai A., Kase A., Uchikado H., Hirayasu Y.: Early effects of olanzapine on serum levels of ghrelin, adiponectin and leptin in patients with schizophrenia. J. Psychopharmacol., 20, 75-79, 2006.
22. Albaugh V.L., Henry C.R., Bello N.T., Hajnal A., Lynch S.L., Halle B., Lynch C.J.: Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents. Obesity (Silver Spring), 14, 36-51, 2006.
23. Minet-Ringuet J., Even P.C., Goubern M., Tome D., de Beaurepaire R.: Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration. Appetite, 46, 254-262, 2006.
24. Hartfield A.W., Moore N.A., Clifton P.G.: Effects of clozapine, olanzapine and haloperidol on the microstructure of ingestive behaviour in the rat. Psychopharmacology, 167, 115-122, 2003.
25. Ishii Y., Blundell J.E., Halford J.C., Rodgers R.J.: Palatability, food intake and the behavioral satiety sequence in male rats. Physiol. Behav., 80, 37-47, 2003.
26. Currie P.J., Coiro C.D., Niyomchai T., Lira A., Farahmand F.: Hypothalamic paraventricular 5-hydroxytryptamine: receptor-specific inhibition of NPY-stimulated eating and energy metabolism. Pharmacol. Biochem. Behav., 71, 709-716, 2002.
27. Ishizuka T., Nomura S., Hosoda H., Kangawa K., Watanabe T., Yamatodani A.: A role of the histaminergic system for the control of feeding by orexigenic peptides. Physiol. Behav., 89, 295-300, 2006.